Patents by Inventor Sanghyung Shim

Sanghyung Shim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOUBLE-STRANDED OLIGO RNA STRUCTURE COMPRISING miRNA
    Publication number: 20210369758
    Abstract: The present invention relates to a double-stranded oligo RNA structure comprising double-stranded miRNA, and a composition for preventing or treating cancer, containing the same. More specifically, the present invention relates to an anti-cancer pharmaceutical composition, containing: a double-stranded oligo RNA structure comprising miR-3670, miR-4477a and miR-8078, and characterized by a method for effectively inhibiting cancer cell proliferation or inducing cancer cell apoptosis; and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: August 13, 2021
    Publication date: December 2, 2021
    Inventors: Taewoo LEE, Sanghyung Shim, Ungsik Yu, Han-Oh Park
  • Double-stranded oligo RNA structure comprising miRNA
    Patent number: 11123361
    Abstract: The present invention relates to a double-stranded oligo RNA structure comprising double-stranded miRNA, and a composition for preventing or treating cancer, containing the same. More specifically, the present invention relates to an anti-cancer pharmaceutical composition, containing: a double-stranded oligo RNA structure comprising miR-3670, miR-4477a and miR-8078, and characterized by a method for effectively inhibiting cancer cell proliferation or inducing cancer cell apoptosis; and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: September 21, 2021
    Assignee: BIONEER CORPORATION
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han-Oh Park
  • DOUBLE-STRANDED OLIGO RNA STRUCTURE COMPRISING miRNA
    Publication number: 20200179432
    Abstract: The present invention relates to a double-stranded oligo RNA structure comprising double-stranded miRNA, and a composition for preventing or treating cancer, containing the same. More specifically, the present invention relates to an anti-cancer pharmaceutical composition, containing: a double-stranded oligo RNA structure comprising miR-3670, miR-4477a and miR-8078, and characterized by a method for effectively inhibiting cancer cell proliferation or inducing cancer cell apoptosis; and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: August 24, 2017
    Publication date: June 11, 2020
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han-Oh Park
  • Pharmaceutical composition for treating cancer comprising microrna as active ingredient
    Patent number: 10612026
    Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
    Type: Grant
    Filed: March 31, 2019
    Date of Patent: April 7, 2020
    Assignee: BIONEER CORPORATION
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park
  • PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING MICRORNA AS ACTIVE INGREDIENT
    Publication number: 20190218555
    Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
    Type: Application
    Filed: March 31, 2019
    Publication date: July 18, 2019
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park
  • Pharmaceutical composition for treating cancer comprising microrna as active ingredient
    Patent number: 10351849
    Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: July 16, 2019
    Assignee: BIONEER CORPORATION
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park
  • PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING MICRORNA AS ACTIVE INGREDIENT
    Publication number: 20180030440
    Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
    Type: Application
    Filed: February 25, 2016
    Publication date: February 1, 2018
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park